Protein– tag –
-
Electrochemical Hemoglobin Biosensor Achieves Ultrasensitive POCT Diagnosis with 0.09 pM Detection Limit
MDPI (Biosensors Journal) International Overview Research in MDPI's Biosensors Journal reports that electrochemical hemoglobin biosensors leverage enzymatic and affinity-based biosensing to achieve molecular specificity for POCT diagnost... -
Estonian Innovators ÄIO and TFTAK Secure €1.94M for DigiFoundry 2.0: Scaling Precision Fermentation for Cost-Efficient Microbial Oils
Industry News/Press Release Estonia Overview Estonian biotech ÄIO and applied research institution TFTAK have secured €1.94 million for their DigiFoundry 2.0 program, aiming to dramatically boost the efficiency and industrial scalability... -
ADM Invests $55.5M in Clinton, Iowa Facility to Expand Precision Fermentation Capacity for High-Value Bio-Based Products
Green Queen Media USA Overview ADM has announced a $55.5 million investment to significantly expand its precision fermentation capabilities at its Clinton, Iowa facility, supported by a $2.23 million grant from the Iowa Economic Developm... -
Samsung Biologics Announces KRW 3 Trillion ($2.18B) Rights Offering to Fund PolyPeptide Group Acquisition and Bio Campus II Expansion, Strengthening CDMO Leadership
PR Newswire South Korea Overview Samsung Biologics has announced a substantial KRW 3 trillion (approximately $2.18 billion) rights offering to finance its acquisition of PolyPeptide Group and the expansion of its Bio Campus II. This stra... -
Monod Bio Licenses AI-Designed Protein Technologies to SignalChem Biotech for Accelerated Custom Luminescent Assay Development
The Scientist Global Overview AI-driven protein design company Monod Bio has entered into a non-exclusive licensing agreement with SignalChem Biotech, enabling the integration of Monod Bio's LuxSit de novo luciferase technology and NovoB... -
A*STAR Successfully Identifies Bispecific Antibody Stability Risks: Enhancing Manufacturability and Robustness of Next-Gen Biologics
A*STAR Singapore Overview Researchers at A*STAR's Bioprocessing Technology Institute (BTI) in Singapore have successfully identified 'labile regions' within bispecific antibodies (BsAbs) that compromise their manufacturing and stability.... -
Molecular Glue Degraders Expand Druggable Proteome in Cancer Research: Simple Structure Boosts CNS Delivery Potential
Facebook USA Overview Molecular glue degraders, small molecules that stabilize interactions between otherwise non-interacting proteins, are expanding the 'druggable' proteome in cancer research through targeted protein degradation. Unlik... -
Scientists Discover POLDIP2 as ‘Molecular Glue’ Controlling Heme, Unlocking Insights for Rare Disease Treatment
YouTube (The Deep Dive Lab) USA Overview Scientists have discovered a novel 'molecular glue' controlling heme production, the essential oxygen-carrying molecule. The mitochondrial protein POLDIP2 utilizes heme as a molecular glue to bind... -
PROTACs vs. Molecular Glues: Comparing Targeted Protein Degraders for Size and Permeability in Drug Selection
Drug Target Review UK Overview PROTACs and molecular glues represent two distinct strategies for targeted protein degradation, each with unique advantages and challenges. PROTACs are bifunctional molecules that recruit an E3 ligase to a ... -
siRNA Therapy Successfully Switches Off Harmful Genes: FDA-Approved Patisiran and Other Drugs for Hereditary Amyloidosis
Works in Progress Magazine UK Overview siRNA therapy is emerging as a promising treatment to slow or halt disease progression by temporarily silencing specific genes. For conditions like hereditary transthyretin amyloidosis, FDA-approved...
